The effectiveness of different dose responses of shockwave therapy on pain, mobility, disability, and quality of life in adults with chronic non-specific low back pain

LINCOLN UNIVERSITY COLLEGE, MALAYSIA0 个研究点目标入组 120 人开始时间: 2026年6月1日最近更新: 2026年8月10日

适应症

干预措施

试验速览

暂无简介。

•a) Adults aged 18–60 years
•b) Physician Diagnosis of CNSLBP (More than 3 months)
•c) The pain is typically located in the area between the costal margins (ribs) and
•the gluteal folds.
•a. Symptoms and Signs: The primary symptom is low back pain (LBP). This may
•be included with or without referred leg pain (e.g., pain above the knee), as long
•as it does not meet the criteria for a specific pathology like radiculopathy.
•d) Visual Analogue Scale (VAS) pain score equal or more than 3/10
•e) Oswestry Disability Index (ODI) equal or more than 30 %
•f) Able to follow instructions and complete questionnaires

•a) Specific LBP causes: disc herniation, spinal stenosis, spondylolisthesis,
•ankylosing spondylitis, tumors, fractures, infections
•b) Neurological deficits
•c) Pregnancy
•d) Contraindications to shockwave therapy (anticoagulant therapy, metal implants
•in region, coagulation disorders, severe osteoporosis)
•e) Severe psychological conditions that might confound the pain or treatment
•response MINI Cog (e.g., severe depression, active substance abuse).

干预措施: Dose–Response Extracorporeal Shockwave Therapy (ESWT) Program for Chronic Non-Specific Low Back Pain

发起方

LINCOLN UNIVERSITY COLLEGE, MALAYSIA